Send Message
Jinan Quickool Chemical Co., Ltd
Jinan Quickool Chemical Co., Ltd
products
Home /

products

Factory Supply Semaglutide Tirzepatide CAS 2023788-19-2 with Fast Shipping to UK, USA, Europe

Product Details

Place of Origin: China

Brand Name: Quickoolchem

Payment & Shipping Terms

Minimum Order Quantity: 50 Grams

Price: Negotiable

Packaging Details: bulk powder, 15mg/tube or customized

Delivery Time: 1-3 working day

Payment Terms: L/C, L/C, D/A, D/P, T/T, Western Union, MoneyGram

Supply Ability: 10 MT/Month

Get Best Price
Contact Now
Specifications
Highlight:

UK USA Europe Semaglutide Tirzepatide

,

CAS 2023788-19-2 Semaglutide Tirzepatide

,

Factory Supply Semaglutide Tirzepatide

Type:
Pharmaceutical Intermediates
Assay:
>99%
Service:
Professional & Rich Experience
Shelf Life:
2 Years
Specification:
1kg/bag 25kg/drum
Solubility:
Soluble In Water
COA:
Available
Appearance:
White To Off-white Powder
Shipping Method:
Air(UPS, FedEx, TNT, EMS) Or Sea
Storage:
Store In A Cool, Dry Place
Origin:
China
CAS:
2023788-19-2
Type:
Pharmaceutical Intermediates
Assay:
>99%
Service:
Professional & Rich Experience
Shelf Life:
2 Years
Specification:
1kg/bag 25kg/drum
Solubility:
Soluble In Water
COA:
Available
Appearance:
White To Off-white Powder
Shipping Method:
Air(UPS, FedEx, TNT, EMS) Or Sea
Storage:
Store In A Cool, Dry Place
Origin:
China
CAS:
2023788-19-2
Description
Factory Supply Semaglutide Tirzepatide CAS 2023788-19-2 with Fast Shipping to UK, USA, Europe

Product Description:

Tirzepatide powder is the raw form of Tirzepatide, a groundbreaking synthetic peptide used primarily for managing type 2 diabetes. This compound is a dual agonist of the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors, which play a critical role in glucose metabolism. By activating both receptors, Tirzepatide enhances insulin secretion in response to elevated blood glucose levels, suppresses the release of glucagon (a hormone that raises blood sugar), and slows gastric emptying. These actions contribute to more effective blood sugar control, especially after meals, which is vital for individuals with type 2 diabetes.

 

In addition to its glucose-lowering effects, Tirzepatide has demonstrated significant potential for promoting weight loss, making it a valuable option for patients struggling with obesity and diabetes. The powder form of Tirzepatide is primarily utilized in pharmaceutical manufacturing and research settings, where it undergoes further processing into injectable formulations for clinical use. As a result, it requires careful handling and precise formulation to ensure safety and efficacy.

 

Tirzepatide is typically administered through subcutaneous injections, with dosages gradually titrated to optimize patient outcomes while minimizing side effects. Its innovative mechanism of action sets it apart from traditional diabetes medications, providing an exciting new avenue for diabetes management. As ongoing research continues to explore the full range of Tirzepatide's effects and potential applications, it represents a significant advancement in the treatment landscape for type 2 diabetes and related metabolic disorders.

 

Technical Parameters:

Products Name:
Tirzepatide
CAS No.: 2023788-19-2
Purity: ≥99.5%
Appearance: White Lyophilized powder
Logo printing: Available
Storage: Cool Dry Place
 

Dosage:

The dosage of Tirzepatide for treating type 2 diabetes, typically follows a gradual titration to minimize side effects and optimize effectiveness. It is administered via subcutaneous injection once weekly.

 

Here’s a general dosing schedule:

 

1. Starting dose: 2.5 mg once a week for the first 4 weeks. This low dose helps the body adjust to the medication.
2. Dose escalation:
After 4 weeks at 2.5 mg, the dose is increased to 5 mg once weekly.
If further blood sugar control is needed, the dose may be increased in 2.5 mg increments every 4 weeks, up to a maximum dose of 15 mg per week.

 

Titration schedule:


Week 1–4: 2.5 mg weekly
Week 5–8: 5 mg weekly
After 8 weeks: Based on effectiveness and tolerance, the dose may be increased to 7.5 mg, 10 mg, 12.5 mg, or 15 mg.


The dosage is tailored to the individual patient’s needs and response to the medication. Higher doses may offer additional benefits for glucose control and weight loss, but they also increase the likelihood of gastrointestinal side effects, such as nausea or diarrhea.

 

Patients should follow the dosage prescribed by their healthcare provider to ensure safety and efficacy.

 

Function:

1. Dual Receptor Agonism:
Tirzepatide acts as a dual agonist for the GLP-1 (glucagon-like peptide-1) receptor and the GIP (glucose-dependent insulinotropic polypeptide) receptor. This unique mechanism enhances its efficacy in managing blood sugar levels.

 

2. Enhanced Insulin Secretion:
By stimulating the GLP-1 and GIP receptors, Tirzepatide increases insulin secretion from the pancreas in response to elevated blood glucose levels. This helps to lower blood sugar levels, especially after meals.

 

3. Reduced Glucagon Levels:
Tirzepatide suppresses the secretion of glucagon, a hormone that increases blood sugar levels. By lowering glucagon levels, it helps to prevent hyperglycemia (high blood sugar).

 

4. Slowed Gastric Emptying:
The medication delays gastric emptying, which leads to a more gradual absorption of glucose into the bloodstream. This results in improved postprandial (after meal) blood sugar control and enhanced satiety.

 

5. Weight Loss:
Tirzepatide promotes significant weight loss by reducing appetite and increasing feelings of fullness. This is particularly beneficial for individuals with type 2 diabetes who may be overweight or obese, as weight management is crucial for improving metabolic health.

 

Packing and Shipping:

Factory Supply Semaglutide Tirzepatide CAS 2023788-19-2 with Fast Shipping to UK, USA, Europe 0

Send your inquiry
Please send us your request and we will reply to you as soon as possible.
Send